Page 3 - Repligen Co News Today

Westfield Capital Management Co. LP raised its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 20.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 294,222 shares of the biotechnology company’s stock after purchasing an additional 49,727 shares during the quarter. Westfield Capital […]

Granite Bay Wealth Management LLC acquired a new stake in shares of Repligen Co. (NASDAQ:RGEN – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 30,744 shares of the biotechnology company’s stock, valued at approximately $5,026,000. Granite Bay Wealth Management LLC owned […]

Brown Capital Management LLC grew its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 0.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,445,213 shares of the biotechnology company’s stock after buying an additional 4,845 shares during the period. Repligen […]

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have earned an average rating of “Moderate Buy” from the eleven brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1-year price objective among […]

Artisan Partners Limited Partnership lifted its holdings in Repligen Co. (NASDAQ:RGEN – Free Report) by 14.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,399,066 shares of the biotechnology company’s stock after purchasing an additional 177,485 shares during […]

Repligen Co. (NASDAQ:RGEN – Get Free Report) insider Christine Gebski sold 3,788 shares of the stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $147.13, for a total transaction of $557,328.44. Following the transaction, the insider now owns 28,787 shares in the company, valued at […]

New York State Common Retirement Fund boosted its position in Repligen Co. (NASDAQ:RGEN – Free Report) by 1.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 436,799 shares of the biotechnology company’s stock after purchasing an additional 4,281 shares during […]

Repligen Co. (NASDAQ:RGEN – Free Report) – Stock analysts at Zacks Research decreased their Q3 2023 EPS estimates for shares of Repligen in a note issued to investors on Thursday, October 26th. Zacks Research analyst S. Ganoria now expects that the biotechnology company will earn $0.18 per share for the quarter, down from their prior […]

Geneva Capital Management LLC decreased its position in shares of Repligen Co. (NASDAQ:RGEN – Free Report) by 5.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 123,606 shares of the biotechnology company’s stock after selling 6,547 shares during the period. Geneva Capital Management LLC’s holdings in Repligen […]

Repligen Co. (NASDAQ:RGEN – Get Free Report)’s stock price traded up 4.6% during trading on Thursday . The company traded as high as $150.43 and last traded at $149.09. 156,091 shares traded hands during trading, a decline of 72% from the average session volume of 561,980 shares. The stock had previously closed at $142.51. Wall […]